{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:45:00Z","timestamp":1790833500972,"version":"4.1.0"},"reference-count":134,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction Biology"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Tobacco use is one of the leading preventable causes of death in developed countries. Since existing medications are only partially effective in treating tobacco smokers, there is a great need for improved medications for smoking cessation. It has been recently proposed that cannabinoid CB<jats:sub>1<\/jats:sub>receptor antagonists represent a new class of therapeutic agents for drug dependence, and notably, nicotine dependence. Here, we will review current evidence supporting the use of this class of drugs for smoking cessation treatment. Pre\u2010clinical studies indicate that nicotine exposure produces changes in endocannabinoid content in the brain. In experimental animals, N\u2010piperidinyl\u20105\u2010(4\u2010chlorophenyl)\u20101\u2010(2,4\u2010dichlorophenyl)\u20104\u2010methylpyrazole\u20103\u2010carboxamide (rimonabant, SR141716) and<jats:italic>N<\/jats:italic>\u2010(piperidin\u20101\u2010yl)\u20105\u2010(4\u2010iodophenyl)\u20101\u2010(2,4\u2010dichlorophenyl)\u20104\u2010methyl\u20101<jats:italic>H<\/jats:italic>\u2010pyrazole\u20103\u2010carboxamide (AM251), two cannabinoid CB<jats:sub>1<\/jats:sub>receptor antagonists, block nicotine self\u2010administration behavior, an effect that may be related to the blockade of the dopamine\u2010releasing effects of nicotine in the brain. Rimonabant also seems efficacious in decreasing the influence of nicotine\u2010associated stimuli over behavior, suggesting that it may act on two distinct neuronal pathways, those implicated in drug\u2010taking behavior and those involved in relapse phenomena. The utility of rimonabant has been evaluated in several clinical trials. It seems that rimonabant is an efficacious treatment for smoking cessation, although its efficacy does not exceed that of nicotine\u2010replacement therapy and its use may be limited by emotional side effects (nausea, anxiety and depression, mostly). Rimonabant also appears to decrease relapse rates in smokers. These findings indicate significant, but limited, utility of rimonabant for smoking cessation.<\/jats:p>","DOI":"10.1111\/j.1369-1600.2008.00113.x","type":"journal-article","created":{"date-parts":[[2008,5,14]],"date-time":"2008-05-14T17:00:14Z","timestamp":1210784414000},"page":"239-252","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Blocking cannabinoid CB<sub>1<\/sub>receptors for the treatment of nicotine dependence: insights from pre\u2010clinical and clinical studies"],"prefix":"10.1111","volume":"13","author":[{"given":"Bernard Le","family":"Foll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Forget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri\u2010Jean","family":"Aubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270008314467"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2007.11.012"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890423349"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300183"},{"key":"e_1_2_7_6_1","unstructured":"AnthenelliRM DespresJP(2004)Effects of rimonabant in the reduction of major cardiovascular risk factors. Results from the STRATUS\u2010US trial (smoking cessation in smokers motivated to quit). American College of Cardiology 53rd Annual Scientific Session New Orleans LA USA."},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050774"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000569"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0560-7"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2004.11.005"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-003-1758-6"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.03.017"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.12.1162"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050992"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-9384(02)00918-6"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(01)00676-1"},{"key":"e_1_2_7_17_1","unstructured":"Canadian Tobacco Use Monitoring Survey (CTUMS)(2006). URLhttp\/\/www.hc\u2010sc.gc.ca\/hl\u2010vs\/tobac\u2010tabac\/research\u2010recherche\/stat\/index_e.html(accessed on 21 April 2008)."},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(02)00118-1"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4152-06.2007"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245916"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02805981"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61721-8"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.98.4.1976"},{"key":"e_1_2_7_24_1","unstructured":"CinciripiniPM AubinHJ DaleLC NiauraR AnthenelliRM Group. atS (2006)Pooled analysis of three short\u2010term randomised double\u2010blind placebo controlled trials with rimonabant 20\u2003mg\/d in smoking cessation. 8th Annual Conference of the SRNT Europe Kusadasi Turkey."},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2005.01.024"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300541"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-200209000-00018"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(99)00047-7"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705931"},{"key":"e_1_2_7_30_1","unstructured":"DaleL(2004)Efficacy of rimonabant in smoking cessation and prevention of post\u2010cessation weight gain: the STRATUS\u2010US trial. 2004 Annual Meeting of the North American Association for the Study of Obesity (NAASO) Las Vegas NV USA."},{"key":"e_1_2_7_31_1","unstructured":"DaleL AnthenelliR DespresJP(2004)Effects of rimonabant in the reduction of major cardiovascular risk factors: results from the STRATUS\u2010US Trial (Smoking Cessation in Smokers Motivated to Quit) and the RIO\u2010LIPIDS Trial (Weight Reducing and Metabolic Effects in Overweight\/Obese Patients with Dyslipidemia).53rd Annual Scientific Session of the American College of Cardiology (ACC): New Orleans LA USA. Abstr. pp. 409\u2013401."},{"key":"e_1_2_7_32_1","volume-title":"The Health Benefits of Smoking Cessation: A Report of the Surgeon General","author":"Department of Health and Human Services","year":"1990"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2005.06.002"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2005.02.021"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00122-9"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.1998.00125.x"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130051153"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-003-1473-3"},{"key":"e_1_2_7_39_1","first-page":"1200","article-title":"US public health service clinical practice guideline: treating tobacco use and dependence","volume":"45","author":"Fiore MC","year":"2000","journal-title":"Respir Care"},{"key":"e_1_2_7_40_1","unstructured":"Food and Drug Administration Endocrinologic and Metabolic Advisory(2007)Briefing Information NDA 21\u2010888 ZIMULTI (rimonabant)\u2010Sanofi Aventis.http:\/\/wwwfdagov\/ohrms\/dockets\/ac\/07\/briefing\/2007\u20104306b1\u2010fda\u2010backgrounderpdf. Accessed 13 March 2008."},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0525-x"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0015-6"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199702100-00014"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2006.04806.x"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2790129"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01442-8"},{"key":"e_1_2_7_47_1","first-page":"325","article-title":"Stimuli associated with drug injections as events that control behavior","volume":"27","author":"Goldberg SR","year":"1975","journal-title":"Pharmacol Rev"},{"key":"e_1_2_7_48_1","first-page":"1771","article-title":"Second\u2010order schedules of drug injection","volume":"34","author":"Goldberg SR","year":"1975","journal-title":"Fed Proc"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7291998"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(83)90408-2"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(02)03344-9"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0305-7"},{"key":"e_1_2_7_53_1","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0022-3565(24)39179-7","article-title":"Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine","volume":"294","author":"Grottick AJ","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-004-1828-4"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.134.3483.943"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.54.2.161"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90629-1"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-19-07489.2000"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1037\/0278-6133.19.3.242"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2007.12.006"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1037\/0278-6133.7.6.575"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1037\/h0090339"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-0813-0"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1992.tb25966.x"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(92)90060-J"},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2002.02049.x"},{"key":"e_1_2_7_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200409150-00028"},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.077974"},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2005.04.005"},{"key":"e_1_2_7_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-004-2021-5"},{"key":"e_1_2_7_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0155-8"},{"key":"e_1_2_7_73_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.070627"},{"key":"e_1_2_7_74_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000230"},{"key":"e_1_2_7_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2004.09.002"},{"key":"e_1_2_7_76_1","doi-asserted-by":"publisher","DOI":"10.1159\/000063629"},{"key":"e_1_2_7_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100885"},{"key":"e_1_2_7_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2005.03.016"},{"key":"e_1_2_7_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1196-x"},{"key":"e_1_2_7_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707399"},{"key":"e_1_2_7_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03694"},{"key":"e_1_2_7_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/346561a0"},{"key":"e_1_2_7_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00649-9"},{"key":"e_1_2_7_84_1","first-page":"754","article-title":"Conditioned cue recovery of responding following prolonged withdrawal from self\u2010administered cocaine in rats: an animal model of relapse","volume":"7","author":"Meil WM","year":"1996","journal-title":"Behav Pharmacol"},{"key":"e_1_2_7_85_1","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.65.3.448"},{"key":"e_1_2_7_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(00)00239-4"},{"key":"e_1_2_7_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/365061a0"},{"key":"e_1_2_7_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(88)90749-4"},{"key":"e_1_2_7_89_1","unstructured":"NiauraR(2005)Long\u2010term treatment with rimonabant for smoking cessation and the maintenance of abstinence: results from STRATUS\u2010WorldWide trial. 11th Annual Meeting and the 7th Annual European Conference of the Society for Research on Nicotine and Tobacco (SRNT) Prague Czech Republic pp. POS1\u2013054."},{"key":"e_1_2_7_90_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1369.052"},{"key":"e_1_2_7_91_1","doi-asserted-by":"crossref","first-page":"7770","DOI":"10.1523\/JNEUROSCI.21-19-07770.2001","article-title":"The role of the primate amygdala in conditioned reinforcement","volume":"21","author":"Parkinson JA","year":"2001","journal-title":"J Neurosci"},{"key":"e_1_2_7_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707464"},{"key":"e_1_2_7_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01476"},{"key":"e_1_2_7_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/34413"},{"key":"e_1_2_7_95_1","doi-asserted-by":"publisher","DOI":"10.1038\/37120"},{"key":"e_1_2_7_96_1","doi-asserted-by":"publisher","DOI":"10.1080\/14622200020032105"},{"key":"e_1_2_7_97_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3695-04.2004"},{"key":"e_1_2_7_98_1","unstructured":"RigottiNA GonzalesD DaleLG LawrenceD Group. ftCS(2007)Efficacy and safety of adding a nicotine patch to rimonabant for smoking cessation: a randomized controlled trial. 2007 Annual Meeting of the Society for Research on Nicotine and Tobacco (SRNT) Austin TX USA pp. Abstr. PA11\u201314."},{"key":"e_1_2_7_99_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-01-00109.2001"},{"key":"e_1_2_7_100_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.122149199"},{"key":"e_1_2_7_101_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3823-03.2004"},{"key":"e_1_2_7_102_1","doi-asserted-by":"crossref","unstructured":"RosecransJA VillanuevaHF(1991)Discriminative stimulus properties of nicotine: mechanisms of transduction.NIDA Res Monogr101\u2013116.","DOI":"10.1037\/e496182006-007"},{"key":"e_1_2_7_103_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39385.413113.25"},{"key":"e_1_2_7_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707460"},{"key":"e_1_2_7_105_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.035063"},{"key":"e_1_2_7_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2007.04.013"},{"key":"e_1_2_7_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(01)02638-5"},{"key":"e_1_2_7_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(02)00967-4"},{"key":"e_1_2_7_109_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5306.1593"},{"key":"e_1_2_7_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00065-9"},{"key":"e_1_2_7_111_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.54.1.1"},{"key":"e_1_2_7_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2007.10.011"},{"key":"e_1_2_7_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00194-0"},{"key":"e_1_2_7_114_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245221"},{"key":"e_1_2_7_115_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002139900348"},{"key":"e_1_2_7_116_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0373-8"},{"key":"e_1_2_7_117_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301476"},{"key":"e_1_2_7_118_1","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2006.167"},{"key":"e_1_2_7_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(83)90030-1"},{"key":"e_1_2_7_120_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050205"},{"key":"e_1_2_7_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(91)90638-9"},{"key":"e_1_2_7_122_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5321.2048"},{"key":"e_1_2_7_123_1","doi-asserted-by":"publisher","DOI":"10.1038\/80577"},{"key":"e_1_2_7_124_1","volume-title":"Nicotine Addiction in Britain: A Report of the Tobacco Advisory Group of the Royal College of Physicians","author":"Tobacco Advisory Group of the Royal College of Physicians","year":"2000"},{"key":"e_1_2_7_125_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1115740"},{"key":"e_1_2_7_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-9384(02)00818-1"},{"key":"e_1_2_7_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2007.11.012"},{"key":"e_1_2_7_128_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0295-x"},{"key":"e_1_2_7_129_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.8.4321"},{"key":"e_1_2_7_130_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1063545"},{"key":"e_1_2_7_131_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0140525X00010372"},{"key":"e_1_2_7_132_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1406"},{"key":"e_1_2_7_133_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432175"},{"key":"e_1_2_7_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(99)00140-9"},{"key":"e_1_2_7_135_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0726-06.2006"}],"container-title":["Addiction Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1369-1600.2008.00113.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1369-1600.2008.00113.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T08:16:13Z","timestamp":1738224973000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1369-1600.2008.00113.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":134,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["10.1111\/j.1369-1600.2008.00113.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1369-1600.2008.00113.x","archive":["Portico"],"relation":{},"ISSN":["1355-6215","1369-1600"],"issn-type":[{"value":"1355-6215","type":"print"},{"value":"1369-1600","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"2008-06-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}